NOV-002, a mimetic of glutathione disulfide

Danyelle M Townsend1, Christopher J Pazoles, Kenneth D Tew

  • 1Medical University of South Carolina, Department of Pharmaceutical Sciences, 173 Ashley Avenue, PO Box 250505, Charleston, SC 29425, USA.

Abstract

Insights

NOV-002, a novel drug mimicking glutathione disulfide, shows promise in cancer treatment. It may reduce chemotherapy side effects and improve treatment effectiveness in oncology patients.

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Oxidative signaling is an underutilized strategy for novel cancer drug development.
  • Current oncology treatments often provide palliative care with significant toxicities.

Purpose of the Study:

  • To review and evaluate clinical and non-clinical findings for NOV-002.
  • NOV-002 is a mimetic of glutathione disulfide.

Main Methods:

  • Analysis of published data and unpublished sponsor information on NOV-002.
  • Literature review on protein S-glutathionylation in cell signaling, proliferation, and cytoskeletal architecture.

Main Results:

  • NOV-002 is a mechanistically novel agent.
  • Potential to mitigate hematologic toxicity associated with chemotherapy.
  • Potential to enhance efficacy when combined with standard chemotherapy.

Conclusions:

  • NOV-002 demonstrates potential as a supportive agent in cancer therapy.
  • Further investigation into NOV-002's role in combination cancer treatment is warranted.

Related Concept Videos

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Preparation and Reactions of Thiols02:33

Preparation and Reactions of Thiols

Thiols are prepared using the hydrosulfide anion as a nucleophile in a nucleophilic substitution reaction with alkyl halides. For instance, bromobutane reacts with sodium hydrosulfide to give butanethiol.
Sulfur Assimilation01:20

Sulfur Assimilation

Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to become...
Preparation and Reactions of Sulfides02:26

Preparation and Reactions of Sulfides

Sulfides are the sulfur analog of ethers, just as thiols are the sulfur analog of alcohol. Like ethers, sulfides also consist of two hydrocarbon groups bonded to the central sulfur atom. Depending upon the type of groups present, sulfides can be symmetrical or asymmetrical. Symmetrical sulfides can be prepared via an SN2 reaction between 2 equivalents of an alkyl halide and one equivalent of sodium sulfide.
Structure and Nomenclature of Thiols and Sulfides02:17

Structure and Nomenclature of Thiols and Sulfides

Thiols and sulfides are sulfur analogs of alcohols and ethers, respectively, where the sulfur atom takes the place of the oxygen atom. Thus, thiols are generally represented as RSH, where R is an alkyl substituent and —SH is the functional group. On the other hand, in sulfides, the central sulfur atom is bonded to two hydrocarbon groups on either side. Depending upon the type of group, sulfides can be either symmetrical or asymmetrical. Both thiols and sulfides display a bent geometry, similar...